LFST vs. HIMS, OPCH, GH, RDNT, SHC, SGRY, PRVA, BTSG, CON, and WGS
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), BrightSpring Health Services (BTSG), Concentra Group Holdings Parent (CON), and GeneDx (WGS). These companies are all part of the "healthcare" industry.
LifeStance Health Group vs.
Hims & Hers Health (NYSE:HIMS) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.
Hims & Hers Health has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500.
Hims & Hers Health has a net margin of 8.19% compared to LifeStance Health Group's net margin of -7.90%. Hims & Hers Health's return on equity of 10.97% beat LifeStance Health Group's return on equity.
63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 6.6% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Hims & Hers Health received 31 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 37.39% of users gave Hims & Hers Health an outperform vote while only 27.91% of users gave LifeStance Health Group an outperform vote.
Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Hims & Hers Health had 32 more articles in the media than LifeStance Health Group. MarketBeat recorded 33 mentions for Hims & Hers Health and 1 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.41 beat Hims & Hers Health's score of 0.35 indicating that LifeStance Health Group is being referred to more favorably in the news media.
Hims & Hers Health presently has a consensus price target of $37.23, indicating a potential upside of 18.32%. LifeStance Health Group has a consensus price target of $8.63, indicating a potential upside of 23.39%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.
Summary
Hims & Hers Health beats LifeStance Health Group on 14 of the 18 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:LFST) was last updated on 3/13/2025 by MarketBeat.com Staff
